JPWO2022015418A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022015418A5 JPWO2022015418A5 JP2023502638A JP2023502638A JPWO2022015418A5 JP WO2022015418 A5 JPWO2022015418 A5 JP WO2022015418A5 JP 2023502638 A JP2023502638 A JP 2023502638A JP 2023502638 A JP2023502638 A JP 2023502638A JP WO2022015418 A5 JPWO2022015418 A5 JP WO2022015418A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- seq
- group
- nos
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025136537A JP2025170319A (ja) | 2020-07-14 | 2025-08-19 | Ｓａｒｓ－ｃｏｖ－２阻害剤 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063051474P | 2020-07-14 | 2020-07-14 | |
| US63/051,474 | 2020-07-14 | ||
| US202063067593P | 2020-08-19 | 2020-08-19 | |
| US63/067,593 | 2020-08-19 | ||
| PCT/US2021/034069 WO2022015418A1 (en) | 2020-07-14 | 2021-05-25 | Sars-cov-2 inhibitors |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025136537A Division JP2025170319A (ja) | 2020-07-14 | 2025-08-19 | Ｓａｒｓ－ｃｏｖ－２阻害剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023542453A JP2023542453A (ja) | 2023-10-10 |
| JPWO2022015418A5 true JPWO2022015418A5 (cg-RX-API-DMAC7.html) | 2024-06-03 |
Family
ID=76808129
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023502638A Pending JP2023542453A (ja) | 2020-07-14 | 2021-05-25 | Ｓａｒｓ－ｃｏｖ－２阻害剤 |
| JP2025136537A Pending JP2025170319A (ja) | 2020-07-14 | 2025-08-19 | Ｓａｒｓ－ｃｏｖ－２阻害剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025136537A Pending JP2025170319A (ja) | 2020-07-14 | 2025-08-19 | Ｓａｒｓ－ｃｏｖ－２阻害剤 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230250134A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4182027A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2023542453A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230038485A (cg-RX-API-DMAC7.html) |
| CN (1) | CN116209672A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021308208A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022015418A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023282281A1 (ja) * | 2021-07-07 | 2023-01-12 | 国立大学法人東京医科歯科大学 | 抗ウイルス活性を有するペプチド、当該ペプチドを含む抗ウイルス剤、当該抗ウイルス剤の製造方法 |
| KR20240177843A (ko) * | 2023-06-20 | 2024-12-30 | 주식회사 엔큐라젠 | SARS-CoV-2스파이크 단백질에 특이적으로 결합하는 펩타이드 및 이의 용도 |
| WO2025101453A1 (en) * | 2023-11-07 | 2025-05-15 | University Of Washington | De novo design of potent minibinder antagonists of il-6r, gp130, and il1-r1 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6900033B2 (en) * | 2001-06-04 | 2005-05-31 | Human Genome Sciences, Inc. | Methods and compositions for modulating ACE-2 activity |
-
2021
- 2021-05-25 AU AU2021308208A patent/AU2021308208A1/en active Pending
- 2021-05-25 JP JP2023502638A patent/JP2023542453A/ja active Pending
- 2021-05-25 KR KR1020237001812A patent/KR20230038485A/ko active Pending
- 2021-05-25 EP EP21739198.6A patent/EP4182027A1/en active Pending
- 2021-05-25 US US18/004,545 patent/US20230250134A1/en active Pending
- 2021-05-25 CN CN202180049677.2A patent/CN116209672A/zh active Pending
- 2021-05-25 WO PCT/US2021/034069 patent/WO2022015418A1/en not_active Ceased
-
2025
- 2025-08-19 JP JP2025136537A patent/JP2025170319A/ja active Pending